drugset / Trial / NCT01646736
Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluation the clinical efficacy and safety profile of glucocorticosteroid combined with oral T2 (chloroform/methanol extract of Tripterygium wilfordii Hook F) in the treatment of patients with lupus nephritis. Open-labeled, randomized, prospective multi-center clinical trial. Observation period of 24 weeks.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-07
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Subject | Tripterygium wilfordii Hook F | Traditional medicine (herbal / TCM) | 20 mg | Oral |
| Background | Prednisone | Other / unclassified | 7.5 mg | — |